622 SAFETY, AND TOLERABILITY OF NIM811, A NOVEL CYCLOPHILIN INHIBITOR FOR HCV, FOLLOWING SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY VOLUNTEERS AND HCV-INFECTED PATIENTS
J. Ke, E. Lawitz, R. Rozier, T. Marbury, N. Nguyen, D. Serra, K. Dole, J. Praestgaard, M. Huang, T. EvansТом:
50
Рік:
2009
Мова:
english
DOI:
10.1016/s0168-8278(09)60624-3
Файл:
PDF, 49 KB
english, 2009